Literature DB >> 17522942

An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution.

Shimul A Shah1, Sean P Cleary, Jensen C C Tan, Alice C Wei, Steve Gallinger, David R Grant, Paul D Greig.   

Abstract

BACKGROUND: The reported survival after liver transplantation (OLT) for early hepatocellular carcinoma (HCC) is superior to the results of liver resection (LR), but few analyses have considered long waiting times and patient drop-offs due to tumor progression.
METHODS: From 1995-2005, 347 patients with HCC were evaluated at our institution and underwent either LR (n = 174) or placed on the OLT waiting list (n = 173). Patients who only underwent ablation were not included. After eliminating patients with 1) incidental tumors after OLT, 2) tumors outside of Milan criteria, 3) preoperative vascular invasion prior to LR and 4) Child-Pugh Class C cirrhosis prior to OLT, 261 patients (LR = 121; OLT = 140) were included in this analysis.
RESULTS: Median follow-up time was 35 months. Median waiting time for OLT was 7.7 months; during this time, 30 patients were taken off the waiting list. Overall survival (OS) from time of listing or LR was not different between the two groups; 1, 3, and 5 year OS after LR was 89%, 75%, and 56% compared with 90%, 70%, and 64% for OLT (P = .84). Only patients who waited <4 months for OLT (n = 67) had better survival than those who underwent LR (P = .05). Patients who waited longer that four months for OLT had a 2.5x higher risk of death in a Cox multivariate model [odds ratio (OR) 2.5; 95% confidence interval (CI): 1.3-5; P = .007].
CONCLUSION: Unless waiting time is short (< 4 months), the survival of patients with early HCC is similar between LR and LT.

Entities:  

Mesh:

Year:  2007        PMID: 17522942     DOI: 10.1245/s10434-007-9443-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  30 in total

1.  Debate: Resection for early hepatocellular carcinoma.

Authors:  Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2008-12-23       Impact factor: 3.452

2.  Accomplishments in 2007 in the management of hepatobiliary cancers.

Authors:  Anthony T C Chan; Yoji Kishi; Stephen L Chan; Jean-Nicolas Vauthey
Journal:  Gastrointest Cancer Res       Date:  2008-05

3.  Optimal treatment for hepatocellular carcinoma in the cirrhotic liver.

Authors:  S A White; D M Manas; S G Farid; K R Prasad
Journal:  Ann R Coll Surg Engl       Date:  2009-10       Impact factor: 1.891

4.  Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.

Authors:  Melanie B Thomas; Deborah Jaffe; Michael M Choti; Jacques Belghiti; Steven Curley; Yuman Fong; Gregory Gores; Robert Kerlan; Phillipe Merle; Bert O'Neil; Ronnie Poon; Lawrence Schwartz; Joel Tepper; Francis Yao; Daniel Haller; Margaret Mooney; Alan Venook
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

Review 5.  Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis.

Authors:  Mashaal Dhir; Elizabeth R Lyden; Lynette M Smith; Chandrakanth Are
Journal:  HPB (Oxford)       Date:  2012-06-19       Impact factor: 3.647

Review 6.  Bridging to liver transplantation in HCC patients.

Authors:  Dagmar Kollmann; Nazia Selzner; Markus Selzner
Journal:  Langenbecks Arch Surg       Date:  2017-07-28       Impact factor: 3.445

7.  Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?

Authors:  Leonidas G Koniaris; David M Levi; Felipe E Pedroso; Dido Franceschi; Andreas G Tzakis; Juan A Santamaria-Barria; Jennifer Tang; Marissa Anderson; Subhasis Misra; Naveenraj L Solomon; Xiaoling Jin; Peter J DiPasco; Margaret M Byrne; Teresa A Zimmers
Journal:  Ann Surg       Date:  2011-09       Impact factor: 12.969

8.  Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma.

Authors:  Peter Gassmann; Tilmann Spieker; Joerg Haier; Fabian Schmidt; Wolf Arif Mardin; Norbert Senninger
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

9.  Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis.

Authors:  Hiroshi Sogawa; Brian Shrager; Ghalib Jibara; Parissa Tabrizian; Sasan Roayaie; Myron Schwartz
Journal:  HPB (Oxford)       Date:  2012-08-30       Impact factor: 3.647

10.  Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.

Authors:  Wing Chiu Dai; See Ching Chan; Kenneth S H Chok; Tan To Cheung; William W Sharr; Albert C Y Chan; Simon H Y Tsang; James Y Y Fung; Ronnie T P Poon; Sheung Tat Fan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.